Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2105
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data ; volume:20 ; number:1 ; day:16 ; month:12 ; year:2019 ; pages:1-17 ; date:12.2019
BMC bioinformatics ; 20, Heft 1 (16.12.2019), 1-17, 12.2019
- Urheber
-
De Velasco Oriol, Javier
Vallejo, Edgar E.
Estrada, Karol
Taméz Peña, José Gerardo
Disease Neuroimaging Initiative, The Alzheimer’s
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12859-019-3158-x
- URN
-
urn:nbn:de:101:1-2020040703032590352494
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- De Velasco Oriol, Javier
- Vallejo, Edgar E.
- Estrada, Karol
- Taméz Peña, José Gerardo
- Disease Neuroimaging Initiative, The Alzheimer’s
- SpringerLink (Online service)
Ähnliche Objekte (12)
Identifying genetic interactions associated with late-onset Alzheimer’s disease
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
Early and late-onset Alzheimer’s disease: What are the differences?
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease
Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles
Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease
Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease
Exploring the role of common regulatory variants in the etiology of late-onset Alzheimer’s disease
Identifying genetic interactions associated with late-onset Alzheimer’s disease
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
Early and late-onset Alzheimer’s disease: What are the differences?
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease
Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles
Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease
Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease
Exploring the role of common regulatory variants in the etiology of late-onset Alzheimer’s disease
Identifying genetic interactions associated with late-onset Alzheimer’s disease
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
Early and late-onset Alzheimer’s disease: What are the differences?
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease
Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles
Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease
Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease